Melanoma Institute Australia Fellowship Program
MIA offers a number of unique clinical and research-based Fellowships each year to train and educate the melanoma clinicians of the future. These Fellowships offer an outstanding opportunity for high-level training in medical oncology, melanoma surgical oncology, melanoma pathology, and dermatology.
Applications are invited from qualified General or Plastic Surgeons for the Melanoma Institute Australia Fellowship in Melanoma and Surgical Oncology.
This program is based at the Melanoma Institute Australia’s North Sydney campus, as well as the Mater Hospital Crows Nest, and Royal Prince Alfred Hospital Camperdown.
This position is formatted at a post Fellowship level (FRACS or equivalent) and is suitable for surgeons seeking to develop a vocational interest in the field.
Each year we offer two clinical and research-based Fellowships, which are for twelve months commencing in February and March 2021. The Fellowships involve a substantial clinical workload in dedicated outpatient clinics, operating sessions and weekly multidisciplinary meetings.
The Melanoma Institute Australia is one of the world’s largest melanoma services, and access to its internationally respected Melanoma Research Database provides the opportunity to undertake significant research during this Fellowship.
Applications are accepted from Australian and non-Australian candidates.
Fellowships are available from February/March 2021 to February/March 2022.
Applications will close 24 April 2020.
Interested candidates should submit the following:
- curriculum vitae
- cover letter highlighting why you want to become an MIA Melanoma Surgery Fellow
- proof of specialist qualification
- current medical registration/licensing
- medical indemnity
- contact details of three referees
Please address your application to:
A/Prof Robyn Saw
Melanoma Institute Australia
40 Rocklands Road
Wollstonecraft NSW 2065
Melanoma Institute Australia (MIA) has two full-time Fellowship positions for medical oncology trainees. These Fellowships will start in February 2021 and be for one year in duration. You must either be a Medical Oncology Trainee or recently qualified RACP Fellow in Medical Oncology (or overseas equivalent).
These positions will provide a unique opportunity for the right individuals to obtain training in the treatment and care of melanoma and complex skin cancer patients in a multidisciplinary, clinical and translational research environment, with an emphasis on management of patients on Ph I, II, III clinical trials, treated with novel targeted and immune therapies.
- Join a world-class organisation in the provision of melanoma care, research and education
- Be at the forefront of immuno-oncology treatment, clinical trials and research
- Opportunity to participate in world-leading clinical research
- A dynamic environment in a recognised centre of excellence
MIA is an independent, non-profit research institute located in North Sydney (NSW, Australia). The Institute is formally affiliated with the University of Sydney and collaborates with clinicians at Royal Prince Alfred Hospital, Royal North Shore Hospital, Westmead Hospital and St Vincent’s and Mater Health to improve the outcome of patients with complex skin cancer. Our team of medical oncologists sees approximately 500 new patients each year and lead a large number of clinical trials of novel agents, including investigator-initiated clinical and translational studies. The Institute has become a major referral centre in Australia, and the care and research conducted by the Institute is widely regarded as world-class.
These positions are based at MIA in North Sydney and will enable the successful applicants to work within a dynamic and high-volume multidisciplinary team focused on the treatment of melanoma, with research links to Westmead Hospital, Royal Prince Alfred and Royal North Shore Hospital. These positions offer an ideal opportunity to the right candidates to work alongside leading medical oncologists, Professor Georgina Long and Associate Professor Alex Menzies to receive training in the care of melanoma patients, gain expertise in the use of immunotherapy and targeted therapy, gain a detailed understanding in the conduct of clinical trials, as well as gain exposure to world-leading clinical and translational research programs.
These positions will involve participation in outpatient multidisciplinary melanoma care, strong involvement in the conduct and medical oversight of medical oncology clinical trials, and the conduct of clinical research programs. The fellows will be expected to participate in the academic activities of the Institute, including conducting research projects for presentation at major international conferences and publication in high ranking journals. Opportunity for part-time postgraduate study for a Masters through The University of Sydney is available, as is the potential to transfer after completion of the fellowship into a full-time PhD at the University of Sydney or Macquarie University.
Applicants need to hold a FRACP part 1 and 2 exam or equivalent, be eligible for registration with the Medical Board of Australia; and have completed (or will have by January 2021) at least 2 core years of advanced training in medical oncology.
Priority is given to Australian candidates.
For UK applicants, you will need to have at least MRCP Part 2 (with PACES preferred) and have equivalent clinical experience at registrar/SHO level in Medical Oncology.
Appropriate regulatory assistance will be given to facilitate the best overall candidates.
Applications close 1 May 2020